Literature DB >> 11993521

Chronic inflammatory demyelinative polyneuropathy.

Gérard Said1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11993521     DOI： 10.1007/s004150200000

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  53 in total

1.  Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy.

Authors:  M Nagamatsu; S Terao; K Misu; M Li; N Hattori; M Ichimura; M Sakai; H Yamamoto; H Watanabe; S Riku; E Ikeda; J Hata; M Oda; M Satake; N Nakamura; S Matsuya; Y Hashizume; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

2.  Chronic inflammatory polyradiculoneuropathy.

Authors:  P J Dyck; A C Lais; M Ohta; J A Bastron; H Okazaki; R V Groover
Journal:  Mayo Clin Proc       Date:  1975-11       Impact factor: 7.616

3.  Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis.

Authors:  N Mowzoon; A Sussman; W G Bradley
Journal:  J Neurol Sci       Date:  2001-04-01       Impact factor: 3.181

4.  Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  J R Mendell; R J Barohn; M L Freimer; J T Kissel; W King; H N Nagaraja; R Rice; W W Campbell; P D Donofrio; C E Jackson; R A Lewis; M Shy; D M Simpson; G J Parry; M H Rivner; C A Thornton; M B Bromberg; R Tandan; Y Harati; M J Giuliani
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

5.  Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.

Authors:  N Yuki; Y Tagawa; S Handa
Journal:  J Neuroimmunol       Date:  1996-10       Impact factor: 3.478

6.  Chronic relapsing polyneuritis.

Authors:  J W Prineas; J G McLeod
Journal:  J Neurol Sci       Date:  1976-04       Impact factor: 3.181

7.  Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study.

Authors:  A F Hahn; C F Bolton; N Pillay; C Chalk; T Benstead; V Bril; K Shumak; M K Vandervoort; T E Feasby
Journal:  Brain       Date:  1996-08       Impact factor: 13.501

8.  IgG monoclonal paraproteinaemia and peripheral neuropathy.

Authors:  A F Bleasel; S H Hawke; J D Pollard; J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

9.  Relapsing corticosteroid-dependent polyneuritis.

Authors:  W B Matthews; D A Howell; R D Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-06       Impact factor: 10.154

10.  Multiple sclerosis associated with peripheral demyelinating neuropathy.

Authors:  G Di Trapani; A Carnevale; R P Cioffi; A R Massaro; P Profice
Journal:  Clin Neuropathol       Date:  1996 May-Jun       Impact factor: 1.368
View more
  2 in total

Review 1.  Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update.

Authors:  Andreas J Steck; Adam Czaplinski; Susanne Renaud
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 2.  An update on the diagnosis and management of the polyneuropathy of POEMS syndrome.

Authors:  Federica Cerri; Yuri Matteo Falzone; Nilo Riva; Angelo Quattrini
Journal:  J Neurol       Date:  2018-09-27       Impact factor: 4.849
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.